Medika d.d. (ZSE:MDKA)
Croatia · Delayed Price · Currency is EUR 4,600.00
0.00 (0.00%)
Inactive · Last trade price on Mar 24, 2026
Medika d.d. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 952.62 | 826.32 | 745.79 | 628.1 | 549.59 |
Other Revenue | 7.26 | 6.12 | 4.69 | - | - |
| 959.88 | 832.45 | 750.49 | 628.1 | 549.59 | |
Revenue Growth (YoY) | 15.31% | 10.92% | 19.49% | 14.28% | 4.00% |
Cost of Revenue | 887.61 | 766.87 | 690.85 | 577.1 | 504.03 |
Gross Profit | 72.27 | 65.57 | 59.64 | 51 | 45.56 |
Selling, General & Admin | 30.91 | 26.21 | 22.93 | 20.62 | 19.18 |
Other Operating Expenses | 13.57 | 11.26 | 10.05 | 9.04 | 7.8 |
Operating Expenses | 50.59 | 42.26 | 37.31 | 33.69 | 30.87 |
Operating Income | 21.68 | 23.32 | 22.33 | 17.31 | 14.69 |
Interest Expense | -2.11 | -2 | -1.73 | -0.37 | -0.59 |
Interest & Investment Income | 13.66 | 3 | 2.28 | 2.65 | 1.4 |
Earnings From Equity Investments | 0.55 | 0.51 | 0.43 | 0.43 | 0.38 |
Currency Exchange Gain (Loss) | - | - | -0.01 | -0.28 | 0.13 |
EBT Excluding Unusual Items | 33.79 | 24.83 | 23.3 | 19.74 | 16 |
Gain (Loss) on Sale of Assets | - | - | 1.08 | 0.9 | 0.08 |
Pretax Income | 33.79 | 24.83 | 24.37 | 20.64 | 16.08 |
Income Tax Expense | 6 | 4.52 | 4.29 | 5.15 | 2.84 |
Net Income | 27.79 | 20.31 | 20.08 | 15.5 | 13.24 |
Net Income to Common | 27.79 | 20.31 | 20.08 | 15.5 | 13.24 |
Net Income Growth | 36.80% | 1.15% | 29.59% | 17.03% | 30.03% |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | - | - | - | 2.56% | 3.59% |
EPS (Basic) | 959.63 | 701.49 | 693.51 | 535.16 | 468.99 |
EPS (Diluted) | 959.63 | 701.49 | 693.51 | 535.16 | 468.99 |
EPS Growth | 36.80% | 1.15% | 29.59% | 14.11% | 25.53% |
Free Cash Flow | 15.9 | -32.16 | 19.58 | 7.33 | 35.88 |
Free Cash Flow Per Share | 549.01 | -1110.66 | 676.38 | 253.26 | 1270.88 |
Dividend Per Share | - | - | 200.000 | 215.000 | 186.284 |
Dividend Growth | - | - | -6.98% | 15.42% | 0.46% |
Gross Margin | 7.53% | 7.88% | 7.95% | 8.12% | 8.29% |
Operating Margin | 2.26% | 2.80% | 2.98% | 2.76% | 2.67% |
Profit Margin | 2.90% | 2.44% | 2.68% | 2.47% | 2.41% |
Free Cash Flow Margin | 1.66% | -3.86% | 2.61% | 1.17% | 6.53% |
EBITDA | 24.24 | 25.39 | 24.09 | 19.36 | 16.62 |
EBITDA Margin | 2.53% | 3.05% | 3.21% | 3.08% | 3.02% |
D&A For EBITDA | 2.55 | 2.07 | 1.75 | 2.05 | 1.93 |
EBIT | 21.68 | 23.32 | 22.33 | 17.31 | 14.69 |
EBIT Margin | 2.26% | 2.80% | 2.98% | 2.76% | 2.67% |
Effective Tax Rate | 17.76% | 18.20% | 17.62% | 24.93% | 17.66% |